Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress. - Popat V; Frankel PH; Ruel NH; Yost SE; Chang S; Wang E; Villella J; Whyte J; Whelan RL; Eng M; Tinsley R; Synold T; et al. (Pleura and peritoneum, 2025)